Ambicom (ABHI) 10-K 14 Nov 14 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Jul. 31, 2014	Nov. 14, 2014	Jan. 31, 2014
Document Information [Line Items]	'	'	'
Entity Registrant Name	'AMBICOM HOLDINGS, INC	'	'
Entity Central Index Key	'0001444310	'	'
Current Fiscal Year End Date	'--07-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Trading Symbol	'ABHI	'	'
Entity Common Stock, Shares Outstanding	'	27,758,046	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Jul-14	'	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2014	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$6,334,781

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Jul. 31, 2014	Jul. 31, 2013
Current assets:	'	'
Cash and cash equivalents	$523,540	$596,871
Accounts receivable, net of allowance for doubtful accounts of $26 and $26 as of July 31, 2014 and 2013, respectively	490	191,835
Inventory, net of reserve balances of $7,352 and $10,360 as of July 31, 2014 and 2013, respectively	64,120	89,732
Prepaid expenses and other current assets	9,839	167,274
Total current assets	597,989	1,045,712
Property and equipment, net	97,563	15,201
Deposit	20,695	20,695
Intangible asset, net	5,082,375	0
Total assets	5,798,622	1,081,608
Current liabilities:	'	'
Accounts payable and accrued liabilities	116,263	39,077
Accounts payable - other	26,842	23,733
Deferred revenue	1,980	381,980
Notes payable - current portion	15,735	0
Total current liabilities	160,820	444,790
Notes payable, net of current	58,978	0
Total liabilities	219,798	444,790
Commitment and contingency (Note 4)	'	'
Stockholders' equity:	'	'
Common stock, $0.008 par value; 125,000,000 shares authorized; 26,162,093 and 10,806,520 shares issued and outstanding at July 31, 2014 and July 31, 2013, respectively	209,294	86,449
Additional paid in capital	16,777,826	11,493,738
Accumulated deficit	-11,420,396	-10,952,519
Total stockholders’ equity	5,578,824	636,818
Total liabilities and stockholders' equity	5,798,622	1,081,608
Series A Preferred Stock [Member]	'	'
Stockholders' equity:	'	'
Preferred stock	10,000	7,050
Total stockholders’ equity	10,000	7,050
Series B Preferred Stock [Member]	'	'
Stockholders' equity:	'	'
Preferred stock	2,100	2,100
Total stockholders’ equity	$2,100	$2,100

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Allowance for doubtful accounts (in dollars)	$26	$26
Inventory valuation reserve (in dollars)	$7,352	$10,360
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	26,162,093	10,806,520
Common stock, shares outstanding	26,162,093	10,806,520
Series A Preferred Stock [Member]	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	10,000,000	7,050,000
Preferred stock, shares outstanding	10,000,000	7,050,000
Series B Preferred Stock [Member]	'	'
Preferred stock, par value (in dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	325,000	325,000
Preferred stock, shares issued	262,475	262,475
Preferred stock, shares outstanding	262,475	262,475

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Sales	$1,941,142	$3,300,472
Cost of sales	805,631	1,547,054
Gross profits	1,135,511	1,753,418
Operating Expenses	'	'
Depreciation and amortization	181,951	6,187
Professional fees	307,503	281,377
Selling and general expenses	1,111,418	962,413
Total operating expenses	1,600,872	1,249,977
Income (loss) from operations	-465,361	503,441
Other income (expense)	'	'
Other income and expense, net	2,000	28,167
Interest expense, net	-2,790	5
Net other expense	-790	28,172
Total income (loss) before income taxes	-466,151	531,613
Income taxes	1,600	1,600
Net income (loss)	($467,751)	$530,013
Net income (loss) per share - basic (in dollars per share)	($0.02)	$0.05
Net income (loss) per share - diluted (in dollars per share)	($0.01)	$0.03
Weighted average shares outstanding — basic (in shares)	26,162,093	10,806,520
Weighted average shares outstanding — diluted (in shares)	36,424,568	18,118,995

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Cash flows from operating activities:	'	'
Net income (loss)	($467,751)	$530,013
Net income (loss) items not affecting cash:	'	'
Depreciation and amortization	181,951	6,187
Stock-based compensation	136,382	100,280
Reduction in bad debt reserve	0	483
Increase (reduction) in reserve for inventory loss	2,128	4,409
Decrease / (Increase) in operating assets:	'	'
Accounts receivable	191,345	23,603
Inventory	23,485	83,963
Other receivables	0	0
Prepaid expense	157,434	-51,875
Intangible Asset	-41,800	'
Deposit	0	0
Increase / (Decrease) in operating liabilities:	'	'
Accounts payable - trade	77,186	-32,813
Accrued payable - other	3,110	-47,607
Unearned revenue	-380,000	-213,024
Net cash provided by operating activities	-116,530	403,619
Cash flows from investing activities:	'	'
Payment of notes to related parties	0	0
Capital expenditures	-106,513	-1,075
Net cash used in investing activities	-106,513	-1,075
Cash flows from financing activities:	'	'
Proceeds from sale of common stock	75,000	'
Proceeds from notes payable	0	0
Payments on notes payable	74,712	-55,000
Net cash provided (used) in financing activities	149,712	-55,000
Net increase in cash and cash equivalents	-73,331	347,544
Cash and cash equivalents, beginning of year	596,871	249,327
Cash and cash equivalents, end of year	523,540	596,871
Supplemental information:	'	'
Income taxes paid	1,600	1,600
Interest paid	$2,790	$0

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Stockholders' Equity (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Series B Preferred Stock [Member]	Series A Preferred Stock [Member]
Balance at Jul. 31, 2012	$6,525	$78,323	$11,401,458	($11,482,406)	$2,100	$7,050
Balance (in shares) at Jul. 31, 2012	'	9,790,760	'	'	262,475	7,050,000
Employee stock option expense	9,680	'	9,680	'	'	'
Investor relations expense	78,600	3,200	75,400	'	'	'
Investor relations expense (in shares)	'	400,000	'	'	'	'
Advisory board expense	12,000	4,800	7,200	'	'	'
Advisory board expense (in shares)	'	600,000	'	'	'	'
Annual 6% common stock dividend for Preferred B holders per Preferred B agreement	0	126	'	-126	'	'
Annual 6% common stock dividend for Preferred B holders per Preferred B agreement (in shares)	'	15,760	'	'	'	'
Net Income	530,013	'	'	530,013	'	'
Balance at Jul. 31, 2013	636,818	86,449	11,493,738	-10,952,519	2,100	7,050
Balance (in shares) at Jul. 31, 2013	'	10,806,520	'	'	262,475	7,050,000
Employee stock option expense	36,432	'	36,432	'	'	'
Investor relations expense	50,000	2,000	48,000	'	'	'
Investor relations expense (in shares)	'	250,000	'	'	'	'
Advisory board expense	47,000	2,000	45,000	'	'	'
Advisory board expense (in shares)	'	250,000	'	'	'	'
Preferred A granted	2,950	'	'	'	'	2,950
Preferred A granted (in shares)	'	'	'	'	'	2,950,000
Annual 6% common stock dividend for Preferred B holders per Preferred B agreement	0	126	'	-126	'	'
Annual 6% common stock dividend for Preferred B holders per Preferred B agreement (in shares)	'	15,760	'	'	'	'
Investor PUT option	75,000	3,435	71,565	0	'	'
Investor PUT option (in shares)	'	429,332	'	'	'	'
Equity Exchange for Assets from Veloxum Corporation	5,198,375	115,284	5,083,091	'	'	'
Equity Exchange for Assets from Veloxum Corporation (in shares)	'	14,410,481	'	'	'	'
Net Income	-467,751	'	'	-467,751	'	'
Balance at Jul. 31, 2014	$5,578,824	$209,294	$16,777,826	($11,420,396)	$2,100	$10,000
Balance (in shares) at Jul. 31, 2014	'	26,162,093	'	'	262,475	10,000,000

Consolidated_Statements_of_Cha1

Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Preferred Stock, Dividend Rate, Percentage	6.00%	6.00%

Organization_and_Principal_Act

Organization and Principal Activities	12 Months Ended
	Jul. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Nature of Operations [Text Block]	'
	Note 1 – Organization and Principal Activities
	AmbiCom Holdings, Inc. (“AmbiCom Holdings” or the ‘Company”) was incorporated as Med Control, Inc. (“Med Control”) under the laws of the State of Nevada on July 1, 2008. Med Control was a development stage enterprise until January 15, 2010. All of Med Control’s activities prior to January 15, 2010 related to its organization, initial funding and share issuances.
	The Company authorized an amendment its Articles of Incorporation (the “Amendment”) to change its name to AmbiCom Holdings, Inc., to increase the number of its authorized shares of capital stock from 75,000,000 to 1,050,000,000 shares of which 1,000,000,000 were designated common stock, par value $0.001 per share (the “Common Stock”) and 50,000,000 were designated preferred stock, par value $0.001 per share (the “Preferred Stock”) and to effect a forward-split such that 131.2335958 shares of Common Stock were issued for every 1 share of Common Stock issued and outstanding immediately prior to filing of the amendment (the “Forward Split”).
	Also on January 15, 2010, the Company acquired AmbiCom Acquisition Corp. a privately owned Nevada corporation (“AmbiCom”), pursuant to an Agreement and Plan of Share Exchange (the “Exchange”). AmbiCom was organized under the laws of the State of Nevada on July 29, 2008. AmbiCom Holdings is a holding company whose operating company, AmbiCom, Inc., is a designer and developer of wireless products focusing on the wireless medical industry. AmbiCom’s wireless modules and devices are based on its innovative application software and Wi-Fi or Bluetooth technologies.
	Pursuant to the terms of the Exchange, the Company acquired AmbiCom from the AmbiCom equity holders in exchange for an aggregate of 20,000,000 newly issued shares of Common Stock, 2,600,000 shares of Series B Preferred Stock, an option to purchase 5,500,000 shares of Common Stock and 2,350,000 shares of Series A Preferred Stock at the purchase price of $0.01 per share, and warrants to purchase 500,000 shares of Common Stock at the exercise price of $0.50 per share (collectively, the “Exchange Shares”). As a result of the Exchange, the AmbiCom equity holders surrendered all of their issued and outstanding capital stock of AmbiCom in consideration for the Exchange Shares and AmbiCom became a wholly-owned subsidiary of the Company.
	Simultaneously upon the Closing, the Company closed an offering (the “Offering”) of its Common Stock at a price of $0.40 per share for an aggregate of 1,250,000 shares of Common Stock for aggregate offering price of $500,000.
	On May 29, 2014, the Company acquired all of the assets of Veloxum Corp., a Delaware corporation (“Veloxum”) in consideration for the issuance of 13,100,437 shares of the Company’s Common Stock. Following the Company’s acquisition of all of Veloxum’s assets, the Company has focused its operations as an optimizer of server’s infrastructure configuration settings.
	Details of the Company’s subsidiary as of July 31, 2014 are as follows:
	Name	Place and Date of	Relationships	Principal Activities
		Establishment/
		Incorporation
	E-Care USA, Inc.	Nevada	Wholly-owned subsidiary of AmbiCom Holdings, Inc.	Designer and developer of wireless home medical devices
		15-Mar-11
	Inter-company accounts and transactions have been eliminated in consolidation.

Basis_of_Presentation

Basis of Presentation	12 Months Ended
	Jul. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Accounting [Text Block]	'
	Note 2 – Basis of Presentation
	The accompanying consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and accounting principles generally accepted in the United States for financial information. The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Significant estimates made in preparing the financial statements include revenue recognition and costs of revenue, inventory valuations, long-lived and intangible asset valuations and loss contingencies. In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the periods presented.
	For financial accounting purposes, the acquisition was a reverse acquisition of the Company by AmbiCom, under the purchase method of accounting, and was treated as a recapitalization with AmbiCom as the acquirer.  Upon consummation of the Exchange, the Company adopted the business plan of AmbiCom.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Jul. 31, 2014
Accounting Policies [Abstract]	'
Business Description and Accounting Policies [Text Block]	'
	Note 3 – Summary of Significant Accounting Policies
	The summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. These accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the financial statements.
	a) Description of Business - The Company is a leading designer and developer of wireless technologies which emphasize wireless medical and other wireless products. We develop the integration of the automated optimization software applications into the OEM project for Personal Computers and Servers.
	b) Segment Information - The Company follows ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information.” Topic 280 requires that a company report financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker currently evaluates the Company’s operations from a number of different operational perspectives including but not limited to a client by client basis. The Company derives all significant revenues from a single reportable operating segment of business. Accordingly, the Company does not report more than one segment; nevertheless, management evaluates, at least annually, whether the Company continues to have one single reportable segment.
	c) Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates, and the differences may be material to the financial statements. Estimates are used primarily in determining the depreciable lives of fixed assets, and inventory valuation. In addition, estimates form the basis for the reserves for sales allowances, accounts receivable and inventory. Various assumptions go into the determination of these estimates. The process of determining significant estimates requires consideration of factors such as historical experience and current and expected economic conditions.
	d) Cash and Cash Equivalents - The Company considers all highly liquid investments and time deposits with original maturities of three months or less when purchased to be cash equivalents. All cash and cash equivalents are maintained with nationally recognized financial institutions.
	e) Allowance for Doubtful Accounts - An allowance for doubtful accounts is computed based on the Company’s historical experience and management’s analysis of possible bad debts. Accounts receivable are shown net of an allowance for doubtful accounts of $26 and $26 as of July 31, 2014 and 2013, respectively.
	f) Inventories - Inventories are stated at the lower of cost or market on an average basis. Inventory reserves are recorded for damaged, obsolete, excess and slow-moving inventory. Market value of inventory is estimated based on the impact of market trends, an evaluation of economic conditions and the value of current orders relating to the future sales of this type of inventory. As of July 31, 2014 and July 31, 2013, the value of the inventory reserve was $7,352 and $10,360 respectively.
	g) Income Taxes - The Company accounts for income taxes pursuant to the FASB ASC Topic 740, "Accounting for Uncertainty in Income Taxes", (“Topic 740”). Topic 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements in accordance with generally accepted accounting principles. The calculation of the Company's tax provision involves the application of complex tax rules and regulations within multiple jurisdictions. The Company's tax liabilities include estimates for all income-related taxes that the Company believes are probable and that can be reasonably estimated. To the extent that the Company’s estimates are understated, additional charges to the provision for income taxes would be recorded in the period in which the Company determines such understatement. If the Company's income tax estimates are overstated, income tax benefits will be recognized when realized. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Topic 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
	h) Identified Intangible Asset – Licensed technology and patents are generally amortized on a straight-line basis over the periods of benefit. We amortize all acquisition-related intangible assets that are subject to amortization over their estimated useful life based on economics benefit.
	The carrying amounts of the intangible assets as of July 31, 2014 are as follows (in thousands, except years):
		Intangible Assets, Gross						Accumulated Amortization						Intangible Assets, Net				Weighted
																		Average
																		Useful
		July 31,				July 31,		July 31,				July 31,		July 31,				Life
		2013		Additions		2014		2013		Expense		2014		2013		July 31, 2014		(Years)
	Developed technology	$	-	$	4,423	$	4,423	$	-	$	-134	$	-134	$	-	$	4,289		7
	Trade names and Other Intangible Asset		-		817		817		-		-24		-24		-		793		7
	Total intangible assets, net	$	-	$	5,240	$	5,240	$	-	$	-158	$	-158	$	-	$	5,082
	Total amortization expense related to intangible assets was $157,800 for the year ended July 31, 2014, all of which was recorded in operating expenses. As of July 31, 2014, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows (in thousands):
				Other		Total
		Developed		Intangible		Intangible
		Technology		Assets		Assets
	2015	$	631	$	117	$	748
	2016		631		117		748
	2017		631		117		748
	2018		631		117		748
	2019		631		117		748
	Thereafter		1,134		208		1,342
	Total intangible assets subject to amortization	$	4,289	$	793	$	5,082
	The increase in intangibles in fiscal 2014 is due to the intangibles assets acquired from former shareholders of Veloxum in May 2014. We perform an annual impairment assessment in the fourth quarter of each year for indefinite-lived intangible assets to determine whether is more likely than not that the carrying value of the assets may not be recoverable.
	For further discussion of identified intangible assets, see “Note 4. Acquisitions” for a further discussion.
	i) Revenue Recognition - The majority of the Company's product revenues are recognized upon shipment or delivery and acceptance of products by customers, when pervasive evidence of a sales arrangement exists, the price is fixed or determinable, the title has transferred and collection of resulting receivables is reasonably assured. For merchandise products, the Company recognizes revenue upon shipment of products, when title is passed and the amount collectible can reasonably be determined. All amounts billed to a customer related to shipping and handling are classified as revenue, while all costs incurred by the Company for shipping and handling are classified as selling expenses. For non-recurring engineering (“NRE”) projects, revenue is recognized for the deliverable portions that meet the revenue recognition criteria that persuasive evidence that an agreement exists, delivery has occurred or services have been rendered, the price is fixed and determinable, and collectability is reasonably assured.
	j) Research and Development Costs - Research and development costs are expensed as incurred.
	k) Stock-Based Compensation - The Company adopted ASC Topic 718 “Share-Based Payment”. As permitted, the Company elected to adopt disclosure-only provisions of ASC 718 in accordance with generally accepted accounting principles. Under the provisions of Topic ASC 718, compensation expense is recognized based on the fair value of options on the grant date.
	l) Fair Value of Financial Instruments - ASC Topic 820, “Fair Value Measurements”, requires disclosure of the level within the fair value hierarchy in which fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). The Company's financial instruments consist of cash and cash equivalents, short-term trade receivables and payables at July 31, 2014 and 2013.
	Fair Value of Financial Instruments
	The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments at:
		2014				2013
		Carrying				Carrying
		amount		Fair value		amount		Fair value
	Financial assets:
	Cash and cash equivalents	$	523,540	$	523,540	$	596,871	$	596,871
	Accounts receivable	$	490	$	490	$	191,835	$	191,835
	Financial liabilities:
	Accounts payable and accrued liabilities	$	143,105	$	143,105	$	62,810	$	62,810
	Notes payable	$	74,713	$	71,545		-		-
	The fair values of the financial instruments shown in the above table represent the amounts that would be received when those assets are sold or that would be paid when those liabilities are transferred in an orderly transaction between market participants at the measurement date. Those fair value measurements maximize the use of observable inputs.
	However, in situations where there is little, if any, market activity for the asset or liability at the measurement date, the fair value measurement reflects the Company’s own judgments about the assumptions that market participants would use in pricing the asset or liability. Those judgments are developed by the Company based on the best information available in the circumstances, including expected cash flows and appropriately risk-adjusted discount rates, available observable and unobservable inputs.
	The Company uses the following methods and assumptions in estimating the fair value disclosures for financial instruments:
	Cash equivalents
	The carrying amount reported in the balance sheets of cash equivalents approximate fair value because of the relatively short time to maturity.
	Accounts receivable
	The carrying amount reported in the balance sheets of accounts receivable approximate fair value because of the relatively short time to maturity.
	Accounts payable and accrued liabilities
	The carrying amount reported in the balance sheets of accrued payable and accrued liabilities approximate fair value because of the relatively short time to maturity.
	Notes payable
	The fair value of the Company’s notes payable are measured using quoted offer-side prices when quoted market prices are available. If quoted market prices are not available, the fair value is determined by discounting the future cash flows of each instrument at rates that reflect rates currently observed in publicly traded debt markets for debt of similar terms to companies with comparable credit risk. For long-term debt measurements, where there are no rates currently observable in publicly traded debt markets of similar terms with comparable credit, the Company uses market interest rates and adjusts that rate for all necessary risks, including its own credit risk.
	Fair Value Hierarchy
	The following table presents the placement in the fair value hierarchy of assets and liabilities that are measured at fair value on a recurring basis at:
				Fair value measurements at
				reporting date using
		July 31,		Quoted prices		Significant		Significant
2014		in active		other		unobservable
		markets for		observable		inputs
		identical		inputs		(Level 3)
		assets		(Level 2)
		(Level 1)
Notes payable	$	74,713					$	71,545
			Fair value measurements at
			reporting date using
	July 31,		Quoted prices		Significant		Significant
	2013		in active		other		unobservable
			markets for		observable		inputs
			identical		inputs		(Level 3)
			assets		(Level 2)
			(Level 1)
Notes payable	$	0					$	0
m) Concentration - Financial instruments which potentially subject the Company to concentrations of credit risk are primarily accounts receivable. The Company performs ongoing credit evaluations of its customers’ financial condition. If the collection of the receivable becomes doubtful, the Company establishes a reserve in an amount determined appropriate for the perceived risk. The Company maintains its cash accounts at commercial banks. From time to time, cash balances maintained in such banks may exceed the insured amount by the Federal Deposit Insurance Corporation (FDIC). As of July 31, 2014 and July 31, 2013, management does not believe they are exposed to any significant risk on their cash balances. The Company’s products are primarily sold to global medical device companies. These customers can be significantly affected by changes in economic, competitive or other factors. The Company makes substantial sales to a relatively few, large customers, where company is seeking to capture more business from other targeted medical device companies.
Three customers accounted for $588 (32%), $584 (31%) and $525 (28%) of receivables at July 31, 2014, while one customer accounted for $190,000 (99%) of receivables at July 31, 2013.
Two customers accounted for $1,070,200 (55%) and $206,250 (11%) of the revenues for the year ended July 31, 2014. One customer accounted for $2,169,800 (66%) of the revenues for the year ended July 31, 2013.
Four vendors accounted for $52,000 (45%), $19,650 (17%), $16,512 (14%) and $14,949 (13%) of accounts payable as of July 31, 2014 and three vendors accounted for $20,000 (54%), $5,054 (13%), and $4,400 (12%) of accounts payable as of July 31, 2013.
One vendor accounted for $708,927 (87%) of the purchases for the year ended July 31, 2014. One vendor accounted for $1,315,697 (88%) of the purchases for the year ended July 31, 2013.
Recent Accounting Pronouncements
FASB ASC Topic 220, “Comprehensive Income” - New authoritative accounting guidance under ASC Topic 220, “Comprehensive Income,” amends prior guidance to require all non-owner changes in stockholders' equity to be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under the two-statement approach, the first statement should present total net income and its components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income, and the total of comprehensive income. The pronouncement should be applied retrospectively and effective for fiscal years, and interim periods within those years, beginning after December 15, 2012. The adoption of this pronouncement did not a material impact on the Company's financial statements.
FASB ASC Topic 350, “Intangible and Other Assets” - New authoritative accounting guidance under ASC Topic 350, “Intangible and Other Assets,”, which allows for an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. Under new guidance, an entity is not required to calculate the fair value of a reporting unit unless the entity determines that it is more likely than not that its fair value is less than its carrying amount. The pronouncement is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The adoption of this pronouncement did not have a material impact on the Company's financial statements.
Management does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have an effect on the accompanying consolidated financial statements.

Acquisitions

Acquisitions	12 Months Ended
	Jul. 31, 2014
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	Note 4.  Acquisitions
	Acquisitions in 2014
	Veloxum
	On May 15, 2014, the Company acquired certain assets of Veloxum, Inc., (“Veloxum”), a privately-held company, relating to its enterprise software in exchange for 13,100,437 shares of common stock which was accounted as an asset purchase. At the time of the acquisition, the Company determined that the fair value of the common stock issued was approximately $5.2 million. The Company is amortizing the fair value of the assets purchased over a period of seven years from the date of acquisition.
	The following table summarizes the fair value of assets acquired and liabilities assumed of $5.2 million:
	Developed technology	$	4,423,375
	Tradenames		816,000
	Total	$	5,240,175
	Impairment Consideration
	Developed technology and trade name would be tested for impairment used on guidelines in Accounting Standards Codification Topic 360-10-35, Impairment or Disposal of Long-Lived Assets
	A long-lived asset or asset group that is held and used should be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount for the long-live asset or asset group might not be recoverable. As a result, a company is not required to perform an impairment analysis if indicators of impairment are not present. Instead, a company would assess the need for an impairment write-down only if an indicator of impairment (also referred to as a triggering event) is present.
	As July 31, 2014, there is no triggering event has occurred which would indicate that the acquired Veloxum developed technology and trade name values may not be recoverable. The strategy and plans that had been put in place at the original acquisition date were still effective and progressing as planned.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Jul. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	Note 5 –Commitments and Contingencies
	The Company leases its office and warehouse. The maturity date for the lease is May 2016. The minimum rental commitment under the lease for the years ended July 31 is:
	Year Ending July 31:
	2015	$	58,007
	2016		49,537
	Total	$	107,544
	The rent expense for the years ended July 31, 2014 and 2013 was $53,675, and $53,675, respectively.

Liquidity_and_Shareholders_Equ

Liquidity and Shareholders' Equity	12 Months Ended
	Jul. 31, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	Note 6 – Liquidity and Shareholders’ Equity
	Cash and cash equivalents were $523,540 and $596,871 at July 31, 2014 and 2013, respectively. The working capital was a positive balance of $437,169 and $600,922 at July 31, 2014 and 2013, respectively.
	Preferred Stock
	The Company's Amended Articles of Incorporation authorizes the issuance of 50,000,000 shares of Preferred Stock, par value $0.001 per share, subject to any limitations prescribed by law, without further vote or action by the stockholders, to issue from time to time shares of preferred stock in one or more series. Each such series of Preferred Stock shall have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as shall be determined by the Company's board of directors, which may include, among others, dividend rights, voting rights, liquidation preferences, conversion rights and preemptive rights.
	Series A Convertible Preferred Stock
	The Company has authorized a total of 10,000,000 shares of Series A Convertible Preferred Stock (the “Series A”).  The Series A is convertible at any time into shares of the Company’s common stock at the conversion rate of one share of Common Stock per each share of Series A converted.  The Series A is treated on an “as converted” basis for both voting and liquidation rights. For the year-ended July 31, 2013, 7,050,000 shares of Series A were issued and outstanding. During the year-ended July 31, 2014, The Company has authorized an increase of 2,950,000 shares of Series A Convertible Preferred Stock (“Series A”). There are currently 10,000,000 shares of Series A outstanding as of July 31, 2014. In June 2011, an amendment was filed with the Secretary of State of Nevada whereby the conversion price of Series A would remain unchanged in event of stock split, stock dividend on the common stock, a reclassification of the common stock or distribution to holders of common stock. If the Company reports net income in two of the following four years following the Exchange, the Series A shall be convertible into Common Stock at the conversion rate of two shares of Common Stock per each share of Series A converted. In December 2013, an amendment was filed with the Secretary of State of Nevada whereby the total of Series A Convertible Preferred Shares authorized increased to 10,000,000 shares.
	Series B Convertible Preferred Stock
	In September 2011, the Company Amended and Restated its Articles of Incorporation. Before the amendment, there were 2,600,000 shares of Series B Convertible Preferred Stock outstanding at $0.001 par value per share as of July 31, 2011. After the amendment, there were 325,000 shares of Series B Convertible Preferred Stock outstanding at $0.008 par value per share as of July 31, 2011.
	For the year-ended July 31, 2013, there were 262,475 shares of Series B Convertible Preferred Stock were issued and outstanding. During the year-ended July 31, 2014, there is no change on shares of Series B. There are currently 262,475 shares of Series B outstanding as of July 31, 2014.
	The Series B accrues annual dividends at the rate of 6% per year in shares of Common Stock at the dividend conversion rate of $1.00.  The Series B, together with any unpaid dividends, is convertible at any time into shares of the Company’s common stock at the conversion rate of one share of Common Stock per for each share of Series B converted.  Following the second anniversary of the Exchange, the Series B, together with any unpaid dividends, shall be convertible into Common Stock at the conversion price of forty cents ($0.40) or seventy percent (70%) of the daily volume weighted average price of the Common Stock for the twenty trading days immediately prior to the conversion.  The Series B is redeemable by the Company, at any time prior to December 31, 2015, in cash at the redemption rate of $1.00 per share of Series B plus any accrued and unpaid dividends.  On December 31, 2015, all outstanding shares of Series B shall be redeemed by the Company at a per share redemption price equal to $1.00 per share of Series B plus an amount of Common Stock equal to the amount of the accrued and unpaid dividend thereon.  The Series B has a liquidation preference of $2,600,000 and ranks prior to the Series A and the Common Stock.  The Series B votes on an “as converted” basis.
	As of the Exchange date, there were fully vested options outstanding to purchase 5,500,000 shares of Common Stock and 2,350,000 shares of Series A Preferred Stock, both at a purchase price of $0.01 per share as well as 10,000,000 shares of Series A Preferred Stock as part of the Exchange.   On July 20, 2011, Mr. Kenneth Cheng exercised all 2,350,000 options for Series A Preferred Stock. On June 1, 2011, 7,050,000 shares for Series A Preferred Stock were issued to Mr. John Hwang as part of the Exchange agreement. On December 10, 2013, 2,950,000 shares of Series A Preferred Stock were issued to Mr. John Hwang as part of the Employment agreement.
	Options
	As of July 31, 2014, there were options issued and outstanding for the purchases of 427,778 shares of Common Stock under 2010 Equity Incentive Plan and 10,000,000 shares of Common Stock under 2014 Equity Incentive Plan.
	2010 Equity Incentive Plan
	On January 15, 2010, the Board and Stockholders approved and adopted the 2010 Equity Incentive Plan (the “2010 Plan”). A copy of the 2010 Plan was attached as Exhibit 10.4 to Form 8-K filed with the Securities and Exchange Commission on January 22, 2010.
	The 2010 Plan is intended to promote the interests of the Company by attracting and retaining exceptional employees, consultants, directors, officers and independent contractors (collectively referred to as the “Participants”), and enabling such Participants to participate in the long-term growth and financial success of the Company. Under the 2010 Plan, the Company may grant stock options, which are intended to qualify as “incentive stock options” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Incentive Stock Options”), non-qualified stock options (the “Nonqualified Stock Options”), stock appreciation rights (“SARs”) and restricted stock awards (the “Restricted Stock Awards”), which are restricted shares of Common Stock (the Incentive Stock Options, the Nonqualified Stock Options, the SARs and the Restricted Stock Awards are collectively referred to as “Incentive Awards”). Incentive Awards may be granted pursuant to the 2010 Plan for 10 years from the Effective Date.
	From time to time, the Company may issue Incentive Awards pursuant to the 2010 Plan.  Each of the awards will be evidenced by and issued under a written agreement. In accordance with the rules of the plan, the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.
	The Board reserved a total of 2,277,778 shares of Common Stock for issuance under the 2010 Plan. If an incentive award granted under the 2010 Plan expires, terminates, is unexercised or is forfeited, or if any shares are surrendered in connection with an incentive award, the shares subject to such award and the surrendered shares will become available for further awards under the Plan.
	The number of shares subject to the 2010 Plan, any number of shares subject to any numerical limit in the 2010 Plan, and the number of shares and terms of any Incentive Award may be adjusted in the event of any change in outstanding Common Stock by reason of any stock dividend, spin-off, stock split, reverse stock split, recapitalization, reclassification, merger, consolidation, liquidation, business combination or exchange of shares, or similar transaction.
	On September 1, 2010, 840,000 options were granted to eight employees at an exercise price of $0.20 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 1.79%; volatility of 40%; expected life of 10 years; and, all option grants without payment of dividends, the Company recognized a non-cash stock compensation charge of $446 for the twelve months ended July 31, 2014 in connection with the issuance and vesting of these options.
	On May 1, 2012, 250,000 options were granted to two employees at an exercise price of $0.09 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 1.79%; volatility of 40%; expected life of 10 years; and, all option grants without payment of dividends, the Company recognized a non-cash stock compensation charge of $3,092 for the twelve months ended July 31, 2014 in connection with the issuance and vesting of these options.
	On September 1, 2012, 75,000 options were granted to two employees at an exercise price of $0.03 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 1.59%; volatility of 67%; expected life of 10 years; and, all option grants without payment of dividends, the Company recognized a non-cash stock compensation charge of $1,525 for the twelve months ended July 31, 2014 in connection with the issuance and vesting of these options.
	On January 15, 2014, 305,000 options were granted to four employees at an exercise price of $0.16 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 2.87%; volatility of 72%; expected life of 10 years; and, all option grants without payment of dividends, the Company recognized a non-cash stock compensation charge $10,225 for the twelve months ended July 31, 2014 in connection with the issuance and vesting of these options.
	On May 15, 2014, 10,000,000 options were granted to three employees at an exercise price of $0.24 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 2.50%; volatility of 73%; expected life of 10 years; and, all option grants without payment of dividends, the Company recognized a non-cash stock compensation charge of $21,144 for the twelve months ended July 31, 2014 in connection with the issuance and vesting of these options.
	At July 31, 2014, 427,778 options remain available for future grant under the 2010 Plan.
	As of July 31, 2014, there were options outstanding under the 2010 Plan to purchase 840,000 shares of Common Stock at a purchase price of $0.20 per share, 250,000 shares of Common Stock at a purchase price of $0.09 per share, 75,000 shares of Common Stock at a purchase price of $0.03 per share, 305,000 shares of Common Stock at a purchase price of $0.16 per share and 1,000,000 shares of Common Stock at a purchase price of $0.24 per share. No options have been exercised since the Plan was created.
	2014 Equity Incentive Plan
	On June 2, 2014, the Board and Stockholders approved and adopted the 2014 Equity Incentive Plan (the “2014 Plan”). A copy of the 2014 Plan was filed with the Securities and Exchange Commission on June 3, 2014 with the Company’s Definitive Information Statement.
	The 2014 Plan is intended to promote the interests of the Company by attracting and retaining exceptional employees, consultants, directors, officers and independent contractors (collectively referred to as the “Participants”), and enabling such Participants to participate in the long-term growth and financial success of the Company. Under the 2014 Plan, the Company may grant stock options, which are intended to qualify as “incentive stock options” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Incentive Stock Options”), non-qualified stock options (the “Nonqualified Stock Options”), stock appreciation rights (“SARs”) and restricted stock awards (the “Restricted Stock Awards”), which are restricted shares of Common Stock (the Incentive Stock Options, the Nonqualified Stock Options, the SARs and the Restricted Stock Awards are collectively referred to as “Incentive Awards”). Incentive Awards may be granted pursuant to the 2014 Plan for 10 years from the Effective Date.
	From time to time, the Company may issue Incentive Awards pursuant to the 2014 Plan.  Each of the awards will be evidenced by and issued under a written agreement. In accordance with the rules of the plan, the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.
	The Board reserved a total of 10,000,000 shares of Common Stock for issuance under the 2014 Plan. If an incentive award granted under the 2014 Plan expires, terminates, is unexercised or is forfeited, or if any shares are surrendered in connection with an incentive award, the shares subject to such award and the surrendered shares will become available for further awards under the Plan.
	The number of shares subject to the 2014 Plan, any number of shares subject to any numerical limit in the 2014 Plan, and the number of shares and terms of any Incentive Award may be adjusted in the event of any change in the Company outstanding Common Stock by reason of any stock dividend, spin-off, stock split, reverse stock split, recapitalization, reclassification, merger, consolidation, liquidation, business combination or exchange of shares, or similar transaction.
	At July 31, 2014, no options had been granted and 10,000,000 options remain available for future grant under the 2014 Plan.
	Common Stock
	In September 2011, the Company Amended and Restated its Articles of Incorporation to effectuate a 1 for 8 reverse stock split by decreasing the authorized shares for issuance from 1,000,000,000 shares of common stock, $0.001 par value per share to 125,000,000 shares of common stock, $0.008 par value per share. Before the amendment, there were 52,577,445 shares outstanding as of July 31, 2011. After the amendment, there were 26,162,093 shares and 10,806,520 outstanding as of July 31, 2014 and July 31, 2013, respectively.
	Kodiak Capital Group LLC Investment Agreement
	On October 31, 2011, we entered into an Investment Agreement and a Registration Rights Agreement with Kodiak Capital Group, LLC (the “Investor”) to purchase up to $1,000,000 of the Company’s Common Stock. In accordance with these agreements, the Company filed a registration statement on Form S-1, which was declared effective on January 25, 2013. The Investment Agreement allows the Company to sell Common Stock in increments of $25,000 at a per share purchase price equal to 80% of the volume weighted average price of the Common Stock over five consecutive trading days.
	On March 25, 2014, the Company sold 120,193 shares of Common Stock for $25,000 to Kodiak Capital Group, LLC (the “Investor”).
	On May 12, 2014, the Company sold 208,333 shares of Common Stock for $25,000 to Kodiak Capital Group, LLC (the “Investor”).
	On May 27, 2014, the Company sold 100,806 shares of Common Stock for $25,000 to Kodiak Capital Group, LLC (the “Investor”).

Gain_on_Settlement

Gain on Settlement	12 Months Ended
	Jul. 31, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	Note 7 –Gain on Settlement
	Litigation settlement
	The Company had an ongoing litigation over accounts receivable and payable with Ambeon Corporation, a related party by virtue of common ownership. The dispute started in 2004 and was settled on August 20, 2008 when the Company agreed to pay a sum of $560,000 and the remaining disputed payable balances were decreased in favor of the Company, and settlement income of $843,572 was realized in year 2008. As of July 31, 2014, the company has paid $559,000 towards the settlement. There is no remaining payment due under the settlement.

Property_and_Equipment

Property and Equipment	12 Months Ended
	Jul. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	Note 8 – Property and Equipment
	Property and equipment are stated at cost. Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets: furniture and fixtures –seven years; machinery and equipment –five years; software – five years; leasehold improvements –the life of the current facility lease. Major additions and betterments are capitalized and repairs and maintenance are charged to operations in the period incurred.
		July 31, 2014		July 31, 2013
	Furniture and fixture	$	27,634	$	27,634
	Machinery and equipment		27,540		26,305
	Software		359,417		359,417
	Leasehold Improvements		5,985		5,985
	Vehicle		105,278		-
			525,854		419,341
	Accumulated depreciation		-428,291		-404,140
	Property and equipment, net	$	97,563	$	15,201

Revolving_Line_of_Credit

Revolving Line of Credit	12 Months Ended
	Jul. 31, 2014
Debt Disclosure [Abstract]	'
Revolving Line of Credit [Text Block]	'
	Note 9 – Revolving Line of Credit
	On May 9, 2011, advances under the credit line were secured with substantially all of the Company’s assets and subject to interest at 1% above the Wall Street Journal prime rate index, and were subject to the following restrictive covenants: (i) the current ratio shall not be less than 1.2 times; (ii) the debt to tangible net worth ratio shall not exceed 2.5 times; and (iii) the quarterly EBITDA shall not be less than $30,000 on a rolling four quarter basis.
	As of July 2014, the Company chose not to renew this credit line and did not have a balance as of July 31, 2014.
	The Company incurred interest expense of $2,790 and $5 during the years ended July 31, 2014, and 2013, respectively.

Notes_Payable

Notes Payable	12 Months Ended
	Jul. 31, 2014
Debt Disclosure [Abstract]	'
Notes Payable [Text Block]	'
	Note 10 - Notes Payable
	Notes payable, which are unsecured, consist of the following as of July 31, 2014 and July 31, 2013:
	Notes Payable Consist of the Following at:
		July 31, 2014		July 31, 2013
	Note payable to Bank of America, Auto Loan	$	74,713	$	-
	Total notes payable		74,713		-
	Less current portion		15,735		-
			15,735		-
	Long-term notes payable	$	58,978	$	-

Income_Taxes

Income Taxes	12 Months Ended
	Jul. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	Note 11 – Income Taxes
	The consolidated income tax expense for the years ended July 31, 2014 and 2013 was determined based upon estimates of the Company’s consolidated effective income tax rates for the years ending July 31, 2014 and 2013, respectively. The difference between the consolidated effective income tax rate and the U.S. federal statutory rate is primarily attributable to state income taxes, and the effect of certain permanent differences.
	FASB Topic 740, Accounting for Uncertainty in Income Taxes, prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Generally accepted accounting principles require that the Company recognizes in the financial statements a liability for tax uncertainty if it is more likely than not that the position will be sustained on an audit, based on the technical merits of the position. They also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods and disclosure. The Company has not recorded any liability for unrecognized tax benefits as of July 31, 2014. There have been no material changes in unrecognized tax benefits at July 31, 2014.
	The Company’s tax returns are subject to examination by federal, state and foreign taxing authorities. As of July 31, 2014, the statute of limitations for examining the Company’s federal income tax returns has not expired for the years ended July 31, 2010 through 2013. As of July 31, 2014, the statutes of limitation for tax examinations in the state of California have not expired for tax returns filed for the years ended July 31, 2009 through 2013.
	The Company provided $1,600 and $1,600 for income taxes in the years ended July 31, 2014 and 2013 respectively. The effective tax rates takes into consideration federal and state minimum tax rates and foreign taxes.
	The Company has accumulated NOLs of $ 2.84 million, which, if unutilized, will begin to expire in 2018. Future tax benefits, which may arise as a result of these losses, have not been recognized in these financial statements, and have been offset by a valuation allowance since there is no assurance that we will be able to utilize these NOLs. Details of future income tax assets are as follows:
	Future income tax assets
		July 31, 2014			July 31, 2013
	NOL available for carry forward	$	2,841,697		$	2,158,886
	R&D credit		338,847			126,278
	Other temporary timing differences		121,916			105,676
			3,302,460			2,390,840
	Effective tax rate		28.83	%		32.78	%
			952,173			783,752
	Net deferred tax asset		952,173			783,752
	Valuation allowance		-952,173			-783,752
		$	-		$	-

Subsequent_Events

Subsequent Events	12 Months Ended
	Jul. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	Note 12 – Subsequent Events
	Management preferred an evaluation of the Company’s activity through date these financial statements were issued to determine if there were any subsequent events to be reported. Management determined there were no reportable events to be disclosed.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jul. 31, 2014
Accounting Policies [Abstract]	'
Description of Business [Policy Text Block]	'
	a) Description of Business - The Company is a leading designer and developer of wireless technologies which emphasize wireless medical and other wireless products. We develop the integration of the automated optimization software applications into the OEM project for Personal Computers and Servers.
Segment Reporting, Policy [Policy Text Block]	'
	b) Segment Information - The Company follows ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information.” Topic 280 requires that a company report financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker currently evaluates the Company’s operations from a number of different operational perspectives including but not limited to a client by client basis. The Company derives all significant revenues from a single reportable operating segment of business. Accordingly, the Company does not report more than one segment; nevertheless, management evaluates, at least annually, whether the Company continues to have one single reportable segment.
Use of Estimates, Policy [Policy Text Block]	'
	c) Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates, and the differences may be material to the financial statements. Estimates are used primarily in determining the depreciable lives of fixed assets, and inventory valuation. In addition, estimates form the basis for the reserves for sales allowances, accounts receivable and inventory. Various assumptions go into the determination of these estimates. The process of determining significant estimates requires consideration of factors such as historical experience and current and expected economic conditions.
Cash and Cash Equivalents, Policy [Policy Text Block]	'
	d) Cash and Cash Equivalents - The Company considers all highly liquid investments and time deposits with original maturities of three months or less when purchased to be cash equivalents. All cash and cash equivalents are maintained with nationally recognized financial institutions.
Allowance for Doubtful Accounts [Policy Text Block]	'
	e) Allowance for Doubtful Accounts - An allowance for doubtful accounts is computed based on the Company’s historical experience and management’s analysis of possible bad debts. Accounts receivable are shown net of an allowance for doubtful accounts of $26 and $26 as of July 31, 2014 and 2013, respectively.
Inventory, Policy [Policy Text Block]	'
	f) Inventories - Inventories are stated at the lower of cost or market on an average basis. Inventory reserves are recorded for damaged, obsolete, excess and slow-moving inventory. Market value of inventory is estimated based on the impact of market trends, an evaluation of economic conditions and the value of current orders relating to the future sales of this type of inventory. As of July 31, 2014 and July 31, 2013, the value of the inventory reserve was $7,352 and $10,360 respectively.
Income Tax, Policy [Policy Text Block]	'
	g) Income Taxes - The Company accounts for income taxes pursuant to the FASB ASC Topic 740, "Accounting for Uncertainty in Income Taxes", (“Topic 740”). Topic 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements in accordance with generally accepted accounting principles. The calculation of the Company's tax provision involves the application of complex tax rules and regulations within multiple jurisdictions. The Company's tax liabilities include estimates for all income-related taxes that the Company believes are probable and that can be reasonably estimated. To the extent that the Company’s estimates are understated, additional charges to the provision for income taxes would be recorded in the period in which the Company determines such understatement. If the Company's income tax estimates are overstated, income tax benefits will be recognized when realized. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Topic 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	'
	h) Identified Intangible Asset – Licensed technology and patents are generally amortized on a straight-line basis over the periods of benefit. We amortize all acquisition-related intangible assets that are subject to amortization over their estimated useful life based on economics benefit.
	The carrying amounts of the intangible assets as of July 31, 2014 are as follows (in thousands, except years):
		Intangible Assets, Gross						Accumulated Amortization						Intangible Assets, Net				Weighted
																		Average
																		Useful
		July 31,				July 31,		July 31,				July 31,		July 31,				Life
		2013		Additions		2014		2013		Expense		2014		2013		July 31, 2014		(Years)
	Developed technology	$	-	$	4,423	$	4,423	$	-	$	-134	$	-134	$	-	$	4,289		7
	Trade names and Other Intangible Asset		-		817		817		-		-24		-24		-		793		7
	Total intangible assets, net	$	-	$	5,240	$	5,240	$	-	$	-158	$	-158	$	-	$	5,082
	Total amortization expense related to intangible assets was $157,800 for the year ended July 31, 2014, all of which was recorded in operating expenses. As of July 31, 2014, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows (in thousands):
				Other		Total
		Developed		Intangible		Intangible
		Technology		Assets		Assets
	2015	$	631	$	117	$	748
	2016		631		117		748
	2017		631		117		748
	2018		631		117		748
	2019		631		117		748
	Thereafter		1,134		208		1,342
	Total intangible assets subject to amortization	$	4,289	$	793	$	5,082
	The increase in intangibles in fiscal 2014 is due to the intangibles assets acquired from former shareholders of Veloxum in May 2014. We perform an annual impairment assessment in the fourth quarter of each year for indefinite-lived intangible assets to determine whether is more likely than not that the carrying value of the assets may not be recoverable.
	For further discussion of identified intangible assets, see “Note 4. Acquisitions” for a further discussion.
Revenue Recognition, Policy [Policy Text Block]	'
	i) Revenue Recognition - The majority of the Company's product revenues are recognized upon shipment or delivery and acceptance of products by customers, when pervasive evidence of a sales arrangement exists, the price is fixed or determinable, the title has transferred and collection of resulting receivables is reasonably assured. For merchandise products, the Company recognizes revenue upon shipment of products, when title is passed and the amount collectible can reasonably be determined. All amounts billed to a customer related to shipping and handling are classified as revenue, while all costs incurred by the Company for shipping and handling are classified as selling expenses. For non-recurring engineering (“NRE”) projects, revenue is recognized for the deliverable portions that meet the revenue recognition criteria that persuasive evidence that an agreement exists, delivery has occurred or services have been rendered, the price is fixed and determinable, and collectability is reasonably assured.
Research and Development Expense, Policy [Policy Text Block]	'
	j) Research and Development Costs - Research and development costs are expensed as incurred.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	k) Stock-Based Compensation - The Company adopted ASC Topic 718 “Share-Based Payment”. As permitted, the Company elected to adopt disclosure-only provisions of ASC 718 in accordance with generally accepted accounting principles. Under the provisions of Topic ASC 718, compensation expense is recognized based on the fair value of options on the grant date.
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	l) Fair Value of Financial Instruments - ASC Topic 820, “Fair Value Measurements”, requires disclosure of the level within the fair value hierarchy in which fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). The Company's financial instruments consist of cash and cash equivalents, short-term trade receivables and payables at July 31, 2014 and 2013.
	Fair Value of Financial Instruments
	The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments at:
		2014				2013
		Carrying				Carrying
		amount		Fair value		amount		Fair value
	Financial assets:
	Cash and cash equivalents	$	523,540	$	523,540	$	596,871	$	596,871
	Accounts receivable	$	490	$	490	$	191,835	$	191,835
	Financial liabilities:
	Accounts payable and accrued liabilities	$	143,105	$	143,105	$	62,810	$	62,810
	Notes payable	$	74,713	$	71,545		-		-
	The fair values of the financial instruments shown in the above table represent the amounts that would be received when those assets are sold or that would be paid when those liabilities are transferred in an orderly transaction between market participants at the measurement date. Those fair value measurements maximize the use of observable inputs.
	However, in situations where there is little, if any, market activity for the asset or liability at the measurement date, the fair value measurement reflects the Company’s own judgments about the assumptions that market participants would use in pricing the asset or liability. Those judgments are developed by the Company based on the best information available in the circumstances, including expected cash flows and appropriately risk-adjusted discount rates, available observable and unobservable inputs.
	The Company uses the following methods and assumptions in estimating the fair value disclosures for financial instruments:
	Cash equivalents
	The carrying amount reported in the balance sheets of cash equivalents approximate fair value because of the relatively short time to maturity.
	Accounts receivable
	The carrying amount reported in the balance sheets of accounts receivable approximate fair value because of the relatively short time to maturity.
	Accounts payable and accrued liabilities
	The carrying amount reported in the balance sheets of accrued payable and accrued liabilities approximate fair value because of the relatively short time to maturity.
	Notes payable
	The fair value of the Company’s notes payable are measured using quoted offer-side prices when quoted market prices are available. If quoted market prices are not available, the fair value is determined by discounting the future cash flows of each instrument at rates that reflect rates currently observed in publicly traded debt markets for debt of similar terms to companies with comparable credit risk. For long-term debt measurements, where there are no rates currently observable in publicly traded debt markets of similar terms with comparable credit, the Company uses market interest rates and adjusts that rate for all necessary risks, including its own credit risk.
	Fair Value Hierarchy
	The following table presents the placement in the fair value hierarchy of assets and liabilities that are measured at fair value on a recurring basis at:
				Fair value measurements at
				reporting date using
		July 31,		Quoted prices		Significant		Significant
		2014		in active		other		unobservable
				markets for		observable		inputs
				identical		inputs		(Level 3)
				assets		(Level 2)
				(Level 1)
	Notes payable	$	74,713					$	71,545
				Fair value measurements at
				reporting date using
		July 31,		Quoted prices		Significant		Significant
		2013		in active		other		unobservable
				markets for		observable		inputs
				identical		inputs		(Level 3)
				assets		(Level 2)
				(Level 1)
	Notes payable	$	0					$	0
Concentration [Policy Text Block]	'
	m) Concentration - Financial instruments which potentially subject the Company to concentrations of credit risk are primarily accounts receivable. The Company performs ongoing credit evaluations of its customers’ financial condition. If the collection of the receivable becomes doubtful, the Company establishes a reserve in an amount determined appropriate for the perceived risk. The Company maintains its cash accounts at commercial banks. From time to time, cash balances maintained in such banks may exceed the insured amount by the Federal Deposit Insurance Corporation (FDIC). As of July 31, 2014 and July 31, 2013, management does not believe they are exposed to any significant risk on their cash balances. The Company’s products are primarily sold to global medical device companies. These customers can be significantly affected by changes in economic, competitive or other factors. The Company makes substantial sales to a relatively few, large customers, where company is seeking to capture more business from other targeted medical device companies.
	Three customers accounted for $588 (32%), $584 (31%) and $525 (28%) of receivables at July 31, 2014, while one customer accounted for $190,000 (99%) of receivables at July 31, 2013.
	Two customers accounted for $1,070,200 (55%) and $206,250 (11%) of the revenues for the year ended July 31, 2014. One customer accounted for $2,169,800 (66%) of the revenues for the year ended July 31, 2013.
	Four vendors accounted for $52,000 (45%), $19,650 (17%), $16,512 (14%) and $14,949 (13%) of accounts payable as of July 31, 2014 and three vendors accounted for $20,000 (54%), $5,054 (13%), and $4,400 (12%) of accounts payable as of July 31, 2013.
	One vendor accounted for $708,927 (87%) of the purchases for the year ended July 31, 2014. One vendor accounted for $1,315,697 (88%) of the purchases for the year ended July 31, 2013.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recent Accounting Pronouncements
	FASB ASC Topic 220, “Comprehensive Income” - New authoritative accounting guidance under ASC Topic 220, “Comprehensive Income,” amends prior guidance to require all non-owner changes in stockholders' equity to be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under the two-statement approach, the first statement should present total net income and its components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income, and the total of comprehensive income. The pronouncement should be applied retrospectively and effective for fiscal years, and interim periods within those years, beginning after December 15, 2012. The adoption of this pronouncement did not a material impact on the Company's financial statements.
	FASB ASC Topic 350, “Intangible and Other Assets” - New authoritative accounting guidance under ASC Topic 350, “Intangible and Other Assets,”, which allows for an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. Under new guidance, an entity is not required to calculate the fair value of a reporting unit unless the entity determines that it is more likely than not that its fair value is less than its carrying amount. The pronouncement is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The adoption of this pronouncement did not have a material impact on the Company's financial statements.
	Management does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have an effect on the accompanying consolidated financial statements.

Organization_and_Principal_Act1

Organization and Principal Activities (Tables)	12 Months Ended
	Jul. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Subsidiaries Establishment and Incorporation [Table Text Block]	'
	Details of the Company’s subsidiary as of July 31, 2014 are as follows:
	Name	Place and Date of	Relationships	Principal Activities
		Establishment/
		Incorporation
	E-Care USA, Inc.	Nevada	Wholly-owned subsidiary of AmbiCom Holdings, Inc.	Designer and developer of wireless home medical devices
		15-Mar-11

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jul. 31, 2014
Accounting Policies [Abstract]	'
Schedule of Intangible Assets and Goodwill [Table Text Block]	'
	The carrying amounts of the intangible assets as of July 31, 2014 are as follows (in thousands, except years):
		Intangible Assets, Gross						Accumulated Amortization						Intangible Assets, Net				Weighted
																		Average
																		Useful
		July 31,				July 31,		July 31,				July 31,		July 31,				Life
		2013		Additions		2014		2013		Expense		2014		2013		July 31, 2014		(Years)
	Developed technology	$	-	$	4,423	$	4,423	$	-	$	-134	$	-134	$	-	$	4,289		7
	Trade names and Other Intangible Asset		-		817		817		-		-24		-24		-		793		7
	Total intangible assets, net	$	-	$	5,240	$	5,240	$	-	$	-158	$	-158	$	-	$	5,082
Finite-lived Intangible Assets Amortization Expense [Table Text Block]	'
	As of July 31, 2014, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows (in thousands):
				Other		Total
		Developed		Intangible		Intangible
		Technology		Assets		Assets
	2015	$	631	$	117	$	748
	2016		631		117		748
	2017		631		117		748
	2018		631		117		748
	2019		631		117		748
	Thereafter		1,134		208		1,342
	Total intangible assets subject to amortization	$	4,289	$	793	$	5,082
Fair Value, by Balance Sheet Grouping [Table Text Block]	'
	The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments at:
		2014				2013
		Carrying				Carrying
		amount		Fair value		amount		Fair value
	Financial assets:
	Cash and cash equivalents	$	523,540	$	523,540	$	596,871	$	596,871
	Accounts receivable	$	490	$	490	$	191,835	$	191,835
	Financial liabilities:
	Accounts payable and accrued liabilities	$	143,105	$	143,105	$	62,810	$	62,810
	Notes payable	$	74,713	$	71,545		-		-
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
	The following table presents the placement in the fair value hierarchy of assets and liabilities that are measured at fair value on a recurring basis at:
				Fair value measurements at
				reporting date using
		July 31,		Quoted prices		Significant		Significant
		2014		in active		other		unobservable
				markets for		observable		inputs
				identical		inputs		(Level 3)
				assets		(Level 2)
				(Level 1)
	Notes payable	$	74,713					$	71,545
				Fair value measurements at
				reporting date using
		July 31,		Quoted prices		Significant		Significant
		2013		in active		other		unobservable
				markets for		observable		inputs
				identical		inputs		(Level 3)
				assets		(Level 2)
				(Level 1)
	Notes payable	$	0					$	0

Acquisitions_Tables

Acquisitions (Tables)	12 Months Ended
	Jul. 31, 2014
Business Combinations [Abstract]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	The following table summarizes the fair value of assets acquired and liabilities assumed of $5.2 million:
	Developed technology	$	4,423,375
	Tradenames		816,000
	Total	$	5,240,175

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Jul. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]	'
	The minimum rental commitment under the lease for the years ended July 31 is:
	Year Ending July 31:
	2015	$	58,007
	2016		49,537
	Total	$	107,544

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Jul. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
	Major additions and betterments are capitalized and repairs and maintenance are charged to operations in the period incurred.
		July 31, 2014		July 31, 2013
	Furniture and fixture	$	27,634	$	27,634
	Machinery and equipment		27,540		26,305
	Software		359,417		359,417
	Leasehold Improvements		5,985		5,985
	Vehicle		105,278		-
			525,854		419,341
	Accumulated depreciation		-428,291		-404,140
	Property and equipment, net	$	97,563	$	15,201

Notes_Payable_Tables

Notes Payable (Tables)	12 Months Ended
	Jul. 31, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'
	Notes Payable Consist of the Following at:
		July 31, 2014		July 31, 2013
	Note payable to Bank of America, Auto Loan	$	74,713	$	-
	Total notes payable		74,713		-
	Less current portion		15,735		-
			15,735		-
	Long-term notes payable	$	58,978	$	-

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Jul. 31, 2014
Income Tax Disclosure [Abstract]	'
Summary of Operating Loss Carryforwards [Table Text Block]	'
	Future income tax assets
		July 31, 2014			July 31, 2013
	NOL available for carry forward	$	2,841,697		$	2,158,886
	R&D credit		338,847			126,278
	Other temporary timing differences		121,916			105,676
			3,302,460			2,390,840
	Effective tax rate		28.83	%		32.78	%
			952,173			783,752
	Net deferred tax asset		952,173			783,752
	Valuation allowance		-952,173			-783,752
		$	-		$	-

Organization_and_Principal_Act2

Organization and Principal Activities (Details) (E-Care USA, Inc. [Member])	12 Months Ended
	Jul. 31, 2014
E-Care USA, Inc. [Member]	'
Subsidiaries Establishment And Incorporation [Line Items]	'
Entity Incorporation, Date of Incorporation	15-Mar-11
Entity Incorporation, State Country Name	'Nevada
Relationship Subsidiary	'Wholly-owned subsidiary of AmbiCom Holdings, Inc.
Subsidiary Or Equity Method Investee Principal Activities	'Designer and developer of wireless home medical devices

Organization_and_Principal_Act3

Organization and Principal Activities (Details Textual) (USD $)	0 Months Ended		1 Months Ended
	15-May-14	Jan. 15, 2010	29-May-14	Jul. 31, 2014	Jul. 31, 2013
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'	'	'
Initial Shares Authorized	'	75,000,000	'	'	'
Shares Authorized After Amendment of Articles of Incorporation	'	1,050,000,000	'	'	'
Common Stock, Shares Authorized	'	'	'	125,000,000	125,000,000
Stockholders' Equity Note, Stock Split	'	'forward-split such that 131.2335958 shares of Common Stock were issued for every 1 share of Common Stock	'	'	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	13,100,437	20,000,000	13,100,437	'	'
Business Combination, Options Issued to Acquire Entity Exercise Price (in dollars per share)	'	$0.01	'	'	'
Business Combination, Warrants Issued to Acquire Entity, Number of Securities Called by Warrants or Rights	'	500,000	'	'	'
Business Combination, Warrants Issued to Acquire Entity Exercise Price (in dollars per share)	'	$0.50	'	'	'
Common Stock Price Value Per Share at Closing of the Offering (in dollars per share)	'	$0.40	'	'	'
Aggregate Common Stock Shares at Closing of Offering	'	1,250,000	'	'	'
Common Stock Aggregate Offering Price Value (in dollars)	'	$500,000	'	'	'
Series A Preferred Stock [Member]	'	'	'	'	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'	'	'
Preferred Stock, Shares Authorized	'	'	'	10,000,000	10,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	'	'	'	0.001	0.001
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	'	2,350,000	'	'	'
Series B Preferred Stock [Member]	'	'	'	'	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'	'	'
Preferred Stock, Shares Authorized	'	'	'	325,000	325,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	'	'	'	0.008	0.008
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	'	2,600,000	'	'	'
Common Stock [Member]	'	'	'	'	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'	'	'
Common Stock, Shares Authorized	'	1,000,000,000	'	'	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	'	5,500,000	'	'	'
Preferred Stock [Member]	'	'	'	'	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'	'	'
Preferred Stock, Shares Authorized	'	50,000,000	'	'	'
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	'	$0.00	'	'	'

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Jul. 31, 2014	Jul. 31, 2013
Intangible Assets, Gross	$0	'
Intangible Assets, Additions	5,240	'
Intangible Assets, Gross	5,240	'
Accumulated Amortization	0	'
Accumulated Amortization, Expense	-158	'
Accumulated Amortization	-158	'
Intangible Assets, Net	5,082	0
Developed Technology Rights [Member]	'	'
Intangible Assets, Gross	0	'
Intangible Assets, Additions	4,423	'
Intangible Assets, Gross	4,423	'
Accumulated Amortization	0	'
Accumulated Amortization, Expense	-134	'
Accumulated Amortization	-134	'
Intangible Assets, Net	4,289	0
Weighted Average Useful Life (Years)	'7 years	'
Trade Names [Member]	'	'
Intangible Assets, Gross	0	'
Intangible Assets, Additions	817	'
Intangible Assets, Gross	817	'
Accumulated Amortization	0	'
Accumulated Amortization, Expense	-24	'
Accumulated Amortization	-24	'
Intangible Assets, Net	$793	$0
Weighted Average Useful Life (Years)	'7 years	'

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details 1) (USD $)	Jul. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
2015	$748	'
2016	748	'
2017	748	'
2018	748	'
2019	748	'
Thereafter	1,342	'
Total intangible assets subject to amortization	5,082	0
Developed Technology Rights [Member]	'	'
2015	631	'
2016	631	'
2017	631	'
2018	631	'
2019	631	'
Thereafter	1,134	'
Total intangible assets subject to amortization	4,289	0
Trade Names [Member]	'	'
2015	117	'
2016	117	'
2017	117	'
2018	117	'
2019	117	'
Thereafter	208	'
Total intangible assets subject to amortization	$793	$0

Summary_of_Significant_Account5

Summary of Significant Accounting Policies (Details 2) (USD $)	Jul. 31, 2014	Jul. 31, 2013	Jul. 31, 2012
Financial assets, Carrying amount:	'	'	'
Cash and cash equivalents, Carrying amount	$523,540	$596,871	$249,327
Accounts receivable, Carrying amount	490	191,835	'
Financial liabilities, Carrying amount:	'	'	'
Accounts payable and accrued liabilities, Carrying amount	143,105	62,810	'
Notes payable, Carrying amount	74,713	0	'
Financial assets, Fair value:	'	'	'
Cash and cash equivalents, Fair value	523,540	596,871	'
Accounts receivable, Fair value	490	191,835	'
Financial liabilities, Fair value:	'	'	'
Accounts payable and accrued liabilities, Fair value	143,105	62,810	'
Notes payable, Fair value	$71,545	$0	'

Summary_of_Significant_Account6

Summary of Significant Accounting Policies (Details 3) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Fair Value Hierarchy Of Assets And Liabilities [Line Items]	'	'
Notes payable	$74,713	$0
Fair Value, Inputs, Level 1 [Member]	'	'
Fair Value Hierarchy Of Assets And Liabilities [Line Items]	'	'
Notes payable	'	'
Fair Value, Inputs, Level 2 [Member]	'	'
Fair Value Hierarchy Of Assets And Liabilities [Line Items]	'	'
Notes payable	'	'
Fair Value, Inputs, Level 3 [Member]	'	'
Fair Value Hierarchy Of Assets And Liabilities [Line Items]	'	'
Notes payable	$71,545	$0

Summary_of_Significant_Account7

Summary of Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Accounting Policies [Line Items]	'	'
Allowance for Doubtful Accounts Receivable, Current (in dollars)	$26	$26
Inventory Valuation Reserves (in dollars)	7,352	10,360
Amortization of Intangible Assets	158,000	'
Vendor 1 [Member]	'	'
Accounting Policies [Line Items]	'	'
Entity Wide Accounts Payable, Major Supplier Amount (in dollars)	52,000	20,000
Entity Wide Accounts Payable, Major Percentage	45.00%	54.00%
Entity Wide Purchase, Major Supplier, Amount (in dollars)	708,927	1,315,697
Entity Wide Purchase, Major Supplier, Percentage	87.00%	88.00%
Vendor 2 [Member]	'	'
Accounting Policies [Line Items]	'	'
Entity Wide Accounts Payable, Major Supplier Amount (in dollars)	19,650	5,054
Entity Wide Accounts Payable, Major Percentage	17.00%	13.00%
Vendor3 [Member]	'	'
Accounting Policies [Line Items]	'	'
Entity Wide Accounts Payable, Major Supplier Amount (in dollars)	16,512	4,400
Entity Wide Accounts Payable, Major Percentage	14.00%	12.00%
Vendor4 [Member]	'	'
Accounting Policies [Line Items]	'	'
Entity Wide Accounts Payable, Major Supplier Amount (in dollars)	14,949	'
Entity Wide Accounts Payable, Major Percentage	13.00%	'
Customer 1 [Member]	'	'
Accounting Policies [Line Items]	'	'
Accounts Receivables from Customers (in dollars)	588	190,000
Entity Wide Receivable, Customer, Percentage	32.00%	99.00%
Entity-Wide Revenue, Major Customer, Amount (in dollars)	1,070,200	2,169,800
Entity Wide Revenue Major Customer Percentage	55.00%	66.00%
Customer 2 [Member]	'	'
Accounting Policies [Line Items]	'	'
Accounts Receivables from Customers (in dollars)	584	'
Entity Wide Receivable, Customer, Percentage	31.00%	'
Entity-Wide Revenue, Major Customer, Amount (in dollars)	206,250	'
Entity Wide Revenue Major Customer Percentage	11.00%	'
Customer 3 [Member]	'	'
Accounting Policies [Line Items]	'	'
Accounts Receivables from Customers (in dollars)	$525	'
Entity Wide Receivable, Customer, Percentage	28.00%	'

Acquisitions_Details

Acquisitions (Details) (USD $)	Jul. 31, 2014
Business Acquisition [Line Items]	'
Fair value of assets acquired and liabilities assumed	$5,240,175
Trade Names [Member]	'
Business Acquisition [Line Items]	'
Fair value of assets acquired and liabilities assumed	816,000
Developed Technology Rights [Member]	'
Business Acquisition [Line Items]	'
Fair value of assets acquired and liabilities assumed	$4,423,375

Acquisitions_Details_Textual

Acquisitions (Details Textual) (USD $)	0 Months Ended		1 Months Ended
In Millions, except Share data, unless otherwise specified	15-May-14	Jan. 15, 2010	29-May-14
Business Acquisition, Equity Interests Issued or Issuable [Line Items]	'	'	'
Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares	13,100,437	20,000,000	13,100,437
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned	$5.20	'	'

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Jul. 31, 2014
Future Minimum Lease Payments for Capital Leases [Line Items]	'
2015	$58,007
2016	49,537
Total	$107,544

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Commitments and Contingencies Disclosure [Line Items]	'	'
Rent Expenses	$53,675	$53,675
Lease Expiration Date	31-May-16	'

Liquidity_and_Shareholders_Equ1

Liquidity and Shareholders' Equity (Details Textual) (USD $)

12 Months Ended

0 Months Ended

1 Months Ended

9 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

Jul. 31, 2014

Jul. 31, 2013

Jul. 31, 2012

12-May-14

27-May-14

Mar. 25, 2014

Oct. 31, 2011

Jul. 31, 2014

Sep. 30, 2011

Jul. 31, 2014

Jul. 31, 2013

Sep. 30, 2011

Jul. 31, 2011

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2013

Jul. 31, 2011

Jun. 01, 2011

Dec. 10, 2013

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2013

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2014

Sep. 01, 2010

Jul. 31, 2014

1-May-12

Jul. 31, 2014

Sep. 01, 2012

Jul. 31, 2014

Jan. 15, 2014

Jul. 31, 2014

15-May-14

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2013

Jul. 31, 2011

Jul. 31, 2011

Kodiak Capital Group LLC Investment Agreement [Member]

Kodiak Capital Group LLC Investment Agreement [Member]

Kodiak Capital Group LLC Investment Agreement [Member]

Kodiak Capital Group LLC Investment Agreement [Member]

Kodiak Capital Group LLC Investment Agreement [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Preferred Stock [Member]

Stock Option [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Series A Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Before Amendment [Member]

After Amendment [Member]

After Amendment [Member]

After Amendment [Member]

After Amendment [Member]

John Hwang [Member]

Stock Option [Member]

Common Stock Issuance One [Member]

Common Stock Issuance Two [Member]

Common Stock Issuance Three [Member]

Common Stock Issuance Four [Member]

Common Stock Issuance Five [Member]

Eight Employees [Member]

Eight Employees [Member]

Two Employees [Member]

Two Employees [Member]

Two Employees 1 [Member]

Two Employees 1 [Member]

Four Employees [Member]

Four Employees [Member]

Three Employees [Member]

Three Employees [Member]

Before Amendment [Member]

After Amendment [Member]

Stockholders' Equity Note [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash and Cash Equivalents, at Carrying Value (in dollars)

$523,540

$596,871

$249,327

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Working Capital, at Carrying Value (in dollars)

437,169

600,922

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

50,000,000

'

10,000,000

10,000,000

'

'

'

'

325,000

325,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000,000

'

'

'

Preferred Stock, Shares Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000,000

7,050,000

'

'

'

'

262,475

262,475

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,950,000

262,475

2,600,000

325,000

Preferred Stock, Par or Stated Value Per Share (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

'

$0.00

$0.00

'

'

'

'

$0.01

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

$0.01

Common Stock, Dividend Rate, Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Issued

26,162,093

10,806,520

'

'

'

'

'

'

1,000,000,000

'

'

125,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Outstanding

26,162,093

10,806,520

'

'

'

'

'

'

'

26,162,093

10,806,520

'

52,577,445

'

5,500,000

'

'

2,350,000

7,050,000

'

2,350,000

'

'

10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Par or Stated Value Per Share (in dollars per share)

$0.01

$0.01

'

'

'

'

'

'

$0.00

'

'

$0.01

'

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversation Rate Preferred Stock (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversation Rate Preferred Stock Year Two (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.40

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversation Rate Preferred Stock Year Two Weighted Average Price Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

70.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Redemption Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

31-Dec-15

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Redemption Price Per Share (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock Liquidation Preference Value (in dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise Price of Options, Description

'the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Capital Shares Reserved for Future Issuance

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,277,778

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

427,778

'

'

'

'

'

840,000

'

250,000

'

75,000

'

305,000

'

10,000,000

'

'

'

'

'

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.20

'

$0.09

'

$0.03

'

$0.16

'

$0.24

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.79%

'

1.79%

'

1.59%

'

2.87%

'

2.50%

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40.00%

'

40.00%

'

67.00%

'

72.00%

'

73.00%

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'10 years

'

'10 years

'

'10 years

'

'10 years

'

'10 years

'

'

'

'

'

Share-based Compensation (in dollars)

136,382

100,280

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

446

'

3,092

'

1,525

'

10,225

'

21,144

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

840,000

250,000

75,000

305,000

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.20

$0.09

$0.03

$0.16

$0.24

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Option Outstanding For Purchase

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

427,778

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum Value Of Common Stock To Be Purchased

'

'

'

'

'

'

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Purchase Price Volume Percentage

'

'

'

'

'

'

'

80.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Common Stock

75,000

'

'

'

'

'

'

25,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

208,333

100,806

120,193

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, New Issues

'

'

'

$25,000

$25,000

$25,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Share-based Compensation, Gross

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,950,000

'

'

'

2,950,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gain_on_Settlement_Details_Tex

Gain on Settlement (Details Textual) (USD $)	1 Months Ended
	Aug. 20, 2008	Aug. 30, 2008	Jul. 31, 2014
Litigation Expense Settlement	$560,000	'	'
Gain (Loss) Related to Litigation Settlement	'	843,572	'
Legal Settlements Payment	'	'	$559,000

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Furniture and fixture	$27,634	$27,634
Machinery and equipment	27,540	26,305
Software	359,417	359,417
Leasehold Improvements	5,985	5,985
Vehicle	105,278	0
Property, Plant and Equipment, Gross	525,854	419,341
Accumulated depreciation	-428,291	-404,140
Property and equipment, net	$97,563	$15,201

Property_and_Equipment_Details1

Property and Equipment (Details Textual)	12 Months Ended
	Jul. 31, 2014
Furniture and Fixtures [Member]	'
Property, Plant and Equipment [Line Items]	'
Property, Plant and Equipment, Estimated Useful Lives	'seven years
Machinery and Equipment [Member]	'
Property, Plant and Equipment [Line Items]	'
Property, Plant and Equipment, Estimated Useful Lives	'five years
Software [Member]	'
Property, Plant and Equipment [Line Items]	'
Property, Plant and Equipment, Estimated Useful Lives	'five years
Leasehold Improvements [Member]	'
Property, Plant and Equipment [Line Items]	'
Property, Plant and Equipment, Estimated Useful Lives	'the life of the current facility lease

Revolving_Line_of_Credit_Detai

Revolving Line of Credit (Details Textual) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Debt Disclosure [Line Items]	'	'
Line of Credit Facility, Interest Rate Description	'advances under the credit line were secured with substantially all of the Company’s assets and subject to interest at 1% above the Wall Street Journal prime rate index	'
Line of Credit Facility, Interest Rate Requirements, Current Ratio, Minimum	'1.2	'
Line of Credit Facility, Interest Rate Requirements, Debt to Tangible Net Worth Ratio, Maximum	'2.5	'
Line of Credit Facility, Quarterly EBITDA on Rolling Four Quarter Basis, Minimum (in dollars)	$30,000	'
Line of Credit Facility, Periodic Payment, Interest	$2,790	$5

Notes_Payable_Details

Notes Payable (Details) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Notes Payable Unsecured Disclosure [Line Items]	'	'
Note payable to Bank of America, Auto Loan	$74,713	$0
Total notes payable	74,713	0
Less current portion	15,735	0
Notes Payable, Noncurrent, Total	58,978	0
Long-term notes payable	$58,978	$0

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
NOL available for carry forward	$2,841,697	$2,158,886
R&D credit	338,847	126,278
Other temporary timing differences	121,916	105,676
Deferred Tax Assets, Gross	3,302,460	2,390,840
Effective tax rate	28.83%	32.78%
Tax Credit Carryforward, Deferred Tax Asset	952,173	783,752
Net deferred tax asset	952,173	783,752
Valuation allowance	-952,173	-783,752
Deferred Tax Assets, Net of Valuation Allowance, Current	$0	$0

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Income Tax Expense (Benefit)	$1,600	$1,600
Operating Loss Carryforwards	$2,840,000	'
Operating Loss Due Date	'	'2018